Global Trends in Gallbladder Cancer Survival: A 30-year Analysis of Cancer Registry Data

Overview

Journal Heliyon

Specialty Social Sciences

Date 2025 Mar 12

PMID 40070950

Authors

Yu-Xuan Xiao

Jun Chen

Zhuo-Ying Li

Yi-Xin Zou

Xiao-Hui Zhou

Wei Zhang

Hong-Lan Li

Evelyne Y Bischof

Yong-Bing Xiang

Affiliations

Soon will be listed here.

Abstract

Background: Gallbladder cancer has historically been characterized with a poor prognosis. This study aims to describe the global patterns and temporal trends in gallbladder cancer survival using data from cancer registries.

Methods: We conducted a systematic review by searching six databases-PubMed, Web of Science, EMBASE, SEER, CNKI, and Wanfang-for using of registry-based data published before January 1, 2024. Survival data were carefully extracted and analyzed from the final set of included studies.

Results: Among the 55 studies included, more than 320,000 people, suggest that survival improvements for gallbladder cancer have stagnated over the past three decades. No significant improvements in 5-year relative survival rates were observed worldwide. After age standardization, the highest 5-year relative survival rate is 30.6 % (Changzhou, China, 2011-2013 and Korea, 2013-2019), while the lowest is 6.0 % (Austria, 1990). The 5-year relative survival rate for gallbladder cancer was generally higher in Asian populations than in other regions. Survival rates were more favorable in younger individuals, with no differences in survival observed between the sexes.

Conclusions: Over the past 30 years, the prognosis of patients with gallbladder cancer has not improved significantly worldwide. There is an urgent need for new treatments for gallbladder cancer as well as simple and effective screening methods to improve the survival rate of gallbladder cancer.

References

Flemming J, Zhang-Salomons J, Nanji S, Booth C . Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study. Cancer. 2016; 122(16):2534-43. DOI: 10.1002/cncr.30074. View

Hundal R, Shaffer E . Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6:99-109. PMC: 3952897. DOI: 10.2147/CLEP.S37357. View

Ouyang G, Liu Q, Wu Y, Liu Z, Lu W, Li S . The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study 2017. Cancer. 2021; 127(13):2238-2250. DOI: 10.1002/cncr.33476. View

Pandey M . Environmental pollutants in gallbladder carcinogenesis. J Surg Oncol. 2006; 93(8):640-3. DOI: 10.1002/jso.20531. View

Zimmermann C, Wolk S, Aust D, Meier F, Saeger H, Ehehalt F . The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma. Sci Rep. 2019; 9(1):12676. PMC: 6722235. DOI: 10.1038/s41598-019-49179-w. View

Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V . An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021; 12(1):4579. PMC: 8319326. DOI: 10.1038/s41467-021-24861-8. View

Roa J, Garcia P, Kapoor V, Maithel S, Javle M, Koshiol J . Gallbladder cancer. Nat Rev Dis Primers. 2022; 8(1):69. DOI: 10.1038/s41572-022-00398-y. View

De Angelis R, Sant M, Coleman M, Francisci S, Baili P, Pierannunzio D . Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2013; 15(1):23-34. DOI: 10.1016/S1470-2045(13)70546-1. View

Tsukuma H, Ajiki W, Ioka A, Oshima A . Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol. 2006; 36(9):602-7. DOI: 10.1093/jjco/hyl068. View

10.

Kang M, Won Y, Lee J, Jung K, Kim H, Kong H . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat. 2022; 54(2):330-344. PMC: 9016309. DOI: 10.4143/crt.2022.128. View

11.

Karim-Kos H, Kiemeney L, Louwman M, Coebergh J, de Vries E . Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation. Int J Cancer. 2011; 130(12):2981-9. DOI: 10.1002/ijc.26315. View

12.

Kim S, Shin D, Yang H, Kim S, Ko Y, Cho B . Public Perceptions on Cancer Incidence and Survival: A Nation-wide Survey in Korea. Cancer Res Treat. 2015; 48(2):775-88. PMC: 4843741. DOI: 10.4143/crt.2014.369. View

13.

Guevara M, Molinuevo A, Salmeron D, Marcos-Gragera R, Carulla M, Chirlaque M . Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN). Cancers (Basel). 2022; 14(10). PMC: 9139549. DOI: 10.3390/cancers14102441. View

14.

Aldossary M, Alayed A, Amr S, Alqahtani S, Alnahawi M, Saad Alqahtani M . Gallbladder cancer in Eastern Province of Saudi Arabia: A retrospective cohort study. Ann Med Surg (Lond). 2018; 35:117-123. PMC: 6170934. DOI: 10.1016/j.amsu.2018.09.020. View

15.

Xu X, Wang J, Duan Q . Effects of surgery on survival of elderly patients with gallbladder cancer: A propensity score matching analysis of the SEER database. Front Oncol. 2023; 13:1083618. PMC: 10016611. DOI: 10.3389/fonc.2023.1083618. View

16.

Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T . Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2015; 23(3):149-57. DOI: 10.1002/jhbp.314. View

17.

Lindner P, Holmberg E, Hafstrom L . Gallbladder cancer - no improvement in survival over time in a Swedish population. Acta Oncol. 2018; 57(11):1482-1489. DOI: 10.1080/0284186X.2018.1478124. View

18.

Zadnik V, Zagar T, Lokar K, Tomsic S, Konjevic A, Zakotnik B . Trends in population-based cancer survival in Slovenia. Radiol Oncol. 2021; 55(1):42-49. PMC: 7877261. DOI: 10.2478/raon-2021-0003. View

19.

Gupta P, Agarwal A, Gupta V, Singh P, Pantola C, Amit S . Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012; 5(2):41-7. PMC: 3369597. View

20.

Zhou Y, Xiang Z, Ma J, Lin Y, Chen Y, Jiang H . Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study. Neoplasma. 2021; 68(4):892-898. DOI: 10.4149/neo_2021_210203N168. View